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Received August 19, 2012; accepted December 10, 2012AbstractBackground: The nature and extent of how patients with motor neuron diseases (MNDs) utilize hospice care in Taiwan remains unclear. This
study aims to investigate the use of hospice care in Taiwan by patients with MND, and those factors that affect the extent, the cost, and the
quality of their hospice treatment and care.
Methods: We analyzed data from hospice care inpatient claims of MNDs, using the National Health Insurance Research Database of Taiwan
during 2005e2010.
Results: Thirty patients and 58 related discharges were enrolled into our study, which consisted of 13 males and 17 females, with a mean age
58.3 years. Of that total, 27 of them (90%) had amyotrophic lateral sclerosis, and four (13.3%) had comorbid cancers; 17 died during hospice
care. Acute low respiratory conditions (31.0%) accounted for the most common acute comorbidity. Noninvasive ventilation care was performed
in only 13 (22.4%) of the discharges. In contrast to nasogastric intubation (40 discharges, 69.0%), no gastrostomy/jejunostomy was noted. These
procedures bore no relationship to results observed in the discharges. Family physicians provided most inpatient hospice services (74.1%).
Respiratory problems were the major causes of death (70.6% of decedents). The mean inpatient costs of hospice care were noticeably reduced
from previously established nationwide mean costs.
Conclusion: Hospice care can save costs for patients with terminal MNDs, and family physicians play a valuable role in caring for these patients.
However, respiratory and feeding problems are prevalent, yet there are proven benefits when noninvasive ventilation care and gastrostomy/
jejunostomy are promoted.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Motor neuron diseases (MNDs) are a group of neurodegen-
erative illnesses involving motor nerves with preserved sensory
functions. Because of their irreversible progression and lack of
available curative treatment, MNDs have been a topic of
considerable discussion in the literature.1 Studies in many* Corresponding author. Dr. Shinn-Jang Hwang, Department of Family
Medicine, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road,
Taipei 112, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2013.03.012academic fields have focused on a range of domains such as
therapeutic developments,2 psychological health issues,3 qual-
ity of life and care,4 the safety of narcotic prescriptions,5,6 and
ethical issues surrounding respiratory or feeding care.7,8
In Taiwan, National Health Insurance (NHI) has been
established since 1995. The NHI program designates MNDs as
catastrophic illnesses and patients are enrolled for hospice care
payments. Under the standard criteria and diagnosis by neu-
rologists, those who are identified as having a catastrophic
illness such as an MND would be exempt from the copayments
incurred due to their corresponding disease in both outpatient
and inpatient services.9 Furthermore, a complete registry ofhinese Medical Association. All rights reserved.
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tient distribution among individual hospitals has been limited,
critical studies of MNDs have also been relatively limited in
Taiwan as well. In the late 1990s, Wu10 presented a descriptive
study of care for patients with MNDs using single-hospital
data. After 2000, Lai and Tseng11 reported the first epidemi-
ologic report of MNDs in Taiwan, demonstrating the increasing
incidence with age and the increasing inpatient costs yearly.
The estimated prevalence and annual incidence of MNDs in
Taiwan are 1.63e2.79/105 population and 1.05/105 population/
year respectively, which are lower than those comparable
numbers as reported in the West.11 However, the characteristics
of hospice care utilization among patients with MND in
Taiwan remain unclear. The aim of this study was to examine
how patients with MND use and are integrated into the hospice
care system in Taiwan, looking at quality of services provided,
costs, patient decision-making, and other issues.
2. Methods2.1. Design and source of studyThis study was conducted using retrospective claim-based
analyses, and collected hospice claims data of discharges
among patients with MNDs from the National Health Insurance
Research Database (NHIRD) from 2005 to 2010. Maintained by
the National Health Research Institute of Taiwan, the NHIRD
provides anonymous and encrypted NHI claims data for local
researchers.12 Under NHIRD authorization, we screened in-pa-
tients’ claims data over 6 years (DD2005.DAT, DD2006.DAT,
DD2007.DAT, DD2008.DAT, DD2009.DAT, and DD2010.DAT)
and collected hospice care discharges of patients with MND by
the InternationalClassification ofDiseases,NinthRevision (ICD-
9) code of 335.2x. Details of patients’ therapeutic procedures
were extracted by linking the corresponding ordering files
(DO2005.DAT, DO2006.DAT, DO2007.DAT, DO2008.DAT,
DO2009.DAT, and DO2010.DAT).2.2. ParametersTable 1
The demographic characteristics of patients with motor neuron diseases
who received hospice care in 2005e2010 (n ¼ 30).
Parameters
Mean age (y) 58.3  14.2
Sex (male/female) 13/17
Classification (%)
Amyotrophic lateral sclerosis 27 (90.0)
Progressive bulbar palsy 1 (3.3)
Pseudobulbar palsy 1 (3.3)
Other motor neuron disease 1 (3.3)Acute and chronic comorbidities were screened by the corre-
sponding ICD-9 codes such as diabetes mellitus (250), stroke
(430-438), cancers (140-239), gastroenterological illnesses (530-
537), hypertensive disease (401-405), acute respiratory failure
(518.81), acute low respiratory conditions (ALRC, 480-487), and
urological infections (590, 595, 597, 599, and 601). The causes of
deathwere extracted according to the corresponding lethal ICD-9
codes of discharges and cause-effect relationships. For instance,
we defined “pneumonia” as the cause of death if the decedent had
coexisting diagnosis of “pneumonia”, ”acute respiratory failure”,
and ”sepsis”. The mean cost of each hospice admission was
calculated in New Taiwan Dollars (NTD).Chronic comorbidities (%)
Diabetes mellitus 2 (6.7)
Stroke 1 (3.3)2.3. Statistical analysis
Cancers 4 (13.3)
Gastroenterologic illness 1 (3.3)
Hypertensive diseases 1 (3.3)
Data were expressed as mean  standard deviation and
percentage (%). SPSS software (SPSS version 17.0, SPSS Inc.,Chicago, IL, USA) was used for statistical analyses, and
descriptive statistics were performed in this study. Chi-square
and Fisher exact tests were used for comparison of results of
discharges and procedures; p < 0.05 was taken as the criterion
for statistical significance. This study was conducted with the
approval of the National Health Research Institute, Republic
of China (Taiwan) (No. 100257).
3. Results
During the study period, a total of 30 patients and 58
related discharges were enrolled, including 13 males and 17
females with a mean age 58.3 years (range 32e86 years).
Twenty-seven of the patients (90%) had amyotrophic lateral
sclerosis; the other three had progressive bulbar palsy, pseu-
dobulbar palsy, and other MND. Four patients (13.3%) suf-
fered from comorbid cancers, including three with ovarian
cancer and one with gastric cancer (Table 1). Seventeen pa-
tients died during hospice care.
Among the 58 discharges of patients with MND, acute low
respiratory conditions (ALRC, 31.0%) and acute respiratory
failure (20.7%) were the most common acute comorbidities.
Noninvasive ventilation care and tracheostomy were per-
formed only on 13 (22.4%) and 2 (3.4%) of those admitted,
respectively, whereas no cardiopulmonary resuscitation or
endotracheal intubation was performed. Nasogastric intuba-
tion was required for 40 of those admitted (69.0%), but no
percutaneous endoscopic gastrostomy/jejunostomy was per-
formed for feeding. Correlations between the aforementioned
procedures and expiry or nonexpiry of discharges did not
achieve statistical significance (all p > 0.05). Most inpatient
hospice care for patients with MND was provided by family
physicians (74.1%), and only 5.2% by neurologists (Table 2).
Among the 17 deceased patients with MND, pneumonia
was the most common cause of death (41.2%). Respiratory
problems, including pneumonia, aspiration pneumonitis/suf-
focation, and acute respiratory failure without involvement of
pneumonia, constituted the major causes of death (70.6% of
deceased patients in total; Table 3).
The mean costs for hospice care inpatients with MNDs
were 47,180  42,009 NTD. These tabulations were much
Table 2
The demographic characteristics of admission records for patients with motor
neuron diseases who received hospice care in 2005e2010 (n ¼ 58).
Parameters
Mean hospital stay (days) 12.8  10.8
Results of admissions (discharged/transferred/died) 37/4/17
Noninvasive ventilation care (%)a 13 (22.4)
Tracheostomy (%) 2 (3.4%)
Nasogastric intubation (%) 40 (69.0)
Percutaneous endoscopic gastrostomy or jejunostomy (%) 0 (0)
Acute comorbidities (%)
Acute low respiratory conditions 18 (31.0)
Acute respiratory failure 12 (20.7)
Urologic infections 6 (10.3)
Sections of admissions (%)
Family medicine 43 (74.1)
Neurology 3 (5.2)
Internal medicine 7 (12.1)
Oncology/hematology 1 (1.7)
Radiation oncology 4 (6.9)
a No cardiopulmonary resuscitation or endotracheal intubation was
performed.
392 S.-C. Kang et al. / Journal of the Chinese Medical Association 76 (2013) 390e394lower than the national mean costs that had been reported
(47,180 NTD vs. 121,392 to 180,897 NTD).11
4. Discussion
Amyotrophic lateral sclerosis is the most common type of
MND and is present in up to 60% of Taiwanese patients with
MND.11 In our current study, the distribution of amyotrophic
lateral sclerosis reflected a centralizing trend (90%) among
those under hospice care. For patients with terminal MND, this
phenomenon implied problems likely to be faced in hospices
such as swallowing difficulty, limb and skin care, and respi-
ratory complications. In contrast to the sex distribution shown
in a previous study,11 more female than male patients with
MND tend to be admitted to hospices. Consequently, it could
be worth investigating the existence and extent of sex differ-
ences in attitude toward hospice care among patients with
MND in Taiwan.
Interestingly, the proportion of chronic comorbidities was
low among our patients under hospice care except for co-
morbid cancers (up to 13.3%). We suppose there might be aTable 3
The causes of death among deceased hospice-care patients with motor neuron
diseases in 2005e2010 (n ¼ 17).
Cause of death (%)
Bacteremia/sepsis, origin undetermined 1 (5.9)
Pneumonia 7 (41.2)
Aspiration pneumonitis/suffocation 1 (5.9)
Acute respiratory failure, without indication of pneumonia 4 (23.5)
MNDsa 2 (11.8)
Other or unclear causesb 2 (11.8)
MND ¼ motor neuron disease.
a The ICD-9 code of these two deceased patients’ records was registered
only as MND.
b The comorbidities of these two deceased patients were registered as gastric
cancer and liver cirrhosis.registration bias as a result of screening via ICD-9 codes. In
order to satisfy claims protocol requirements, the diagnoses of
hospice care inpatients may focus on the major diagnosis
indicated for hospice care together with relevant complica-
tions. Linking and comparing the corresponding outpatient
databases or medical records could be a possible solution.
For respiratory care, our results show a low utilization of
noninvasive ventilation (22.4%). In developed countries, it has
been shown that noninvasive ventilation care is advantageous
for maintaining quality of life among patients with MND, even
in hospices or under home care.13,14 Furthermore, noninvasive
ventilation has been recommended for patients with respira-
tory failure.15 According to the results of our investigation,
this procedure did not affect the prognosis of hospice care; i.e.,
it maintained patients’ care quality rather than prolonged lives.
Because of its noninvasive characteristics, we suggest that
noninvasive ventilation care should be promoted before tra-
cheostomy among Taiwanese patients with MND.
The prevalence of invasive feeding procedures varied
greatly by type in our study. For instance, 69.0% of hospice
admissions underwent nasogastric intubation, but no patient
underwent gastrostomy or jejunostomy for feeding. We sup-
pose that this difference can be attributed to traditional con-
cepts of end-of-life body image, which are common among the
elderly in Taiwan. Patients are more willing to endure un-
comfortable nasogastric insertions and related complications
rather than undergoing gastrostomy in order to maintain a
complete body image at the ends of their lives. Similar con-
siderations of end-of-life body image may also explain the low
incidence of tracheostomy in our study, although tracheostomy
care has been demonstrated to increase the long-term survival
of patients with MND.16, 17 Experience in developed countries
shows that early involvement of palliative gastrostomy en-
hances the quality of care for patients with MND.8 Gastro-
stomy has been shown to increase the survival rate of patient
with MND.18 Dysphagia and related malnutrition correlate
with a poor prognosis among such patients.19 We suggest that
palliative gastrostomy/jejunostomy should be promoted for
patients with MND in Taiwan.
Among acute comorbidities, ALRC accounted for a third of
the admission records for hospice care patients with MND.
Furthermore, one-fifth of those admissions suffered acute
respiratory failure. This shows that respiratory complications
and infections remain the major challenges for these patients
in hospices. On the basis of informed consent and symptom-
atic palliation, hospice care could solve some of the ethical
dilemmas and controversies that arise in acute ward care for
patients with MND.7
In Taiwan, family physicians and radiation oncologists
provide most of the hospice care among patients with can-
cers.20 The characteristics of physician manpower in hospices
can be traced back to the inception of hospice care in Taiwan.
Essentially, hospice care was introduced by radiation oncolo-
gists in Taiwan in the 1980s, with later legislated and enrolled
NHI payment since 2000. By the end of 2010, there were 43
hospital-affiliated hospices and 647 ward beds for such ser-
vices.21 Our results revealed that family physicians provided
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neurologists only provided 5.2% of such care. The decision-
making process among terminal noncancer patients
regarding their choice of specialties for hospice care in Taiwan
remains unclear. However, derived from our own experience
of caring for patients with MND, we suppose that family
physicians could play a similar hospice care role for noncancer
patients, and relevant future studies to explore this are
indicated.
The causes of death among patients with terminal MND
have been described in developed countries.22,23 In developing
countries, dysphagia-related malnutrition due to the underly-
ing scarcity of medical resources also contributes noticeably to
death.24 As in the aforementioned studies, respiratory prob-
lems including pneumonia, aspiration pneumonitis/suffoca-
tion, and acute respiratory failure without involvement of
pneumonia are the most common causes of death in our
hospice care patients. This again demonstrates the importance
of adequate respiratory care for symptomatic palliation in
patients with terminal MND. In addition, there are still sudden
deaths and unclear causes of death among these patients.
There is a wide variation in prevalence among different
endemic studies (0.7% in France, 3.6% in People’s Republic
of China, and 12.6% in Italy). Our results indicated 11.8%
among the 17 deceased patients. This phenomenon reflects
underlying patientephysician controversies in acute ward
care, and increasing difficulties in preparing for death in
hospice care. Physicians and healthcare workers should keep
this in mind and explain the terminal phase of patient care
carefully to patients with MND and their families.
It is known that patientswithMNDincur highmedical costs. In
theUnited States, a systemic sampling study demonstrated higher
inpatient costs for MNDs than for non-MND illnesses.25 Another
nationwide cohort study revealed an increasing trend of inpatient
costs over 15 years.26 A similar increasing trend of inpatient costs
was found among patients with MND in Taiwan.11 Compared
with mean costs in Taiwan nationwide as shown in previous re-
ports, our current results show much lower mean inpatient costs
under hospice care. Furthermore, if we focused on 2005 data
(DD2005.DAT) and conducted our calculations using previous
epidemiologic results,11 the mean inpatient costs were much
lower in patients with MND under hospice care than those under
acutewardcare (73,734.5 vs. 121,914.0NTD).Most patientswith
MND underwent acuteward care instead of hospice care (365 vs.
4 admission records in 2005). The phenomenon reflected the
nonaggressive role of hospice care for patients with MND at that
time, which might be viewed as predying preparation or removal
of ventilation care. Under the fixed payment of NHI, hospice care
has previously been shown to be cost saving in local terminal
cancer patients.27 Notwithstanding the aforementioned results
and epidemiologic reports, the utilization of hospice care remains
extremely low among patients with MND in Taiwan. Because of
the symptomatic palliation it provides and considerations of cost-
efficiency, there is room to promote hospice care for patients with
terminal MND.
There are several inevitable limitations to this study.
Descriptive statistics were performed instead of comparisonsamong variables because of the limited number of patients.
Registration bias could not be excluded by screening ICD-9
codes, especially for chronic comorbidities, which may be
viewed as less important for claims than acute comorbidities.
Psychological issues could not be approached by claim-based
analyses. Additionally, epidemiologic data after 2005 are still
unavailable in Taiwan. Issues concerning prescriptions were
not investigated because of technical difficulties, such as
measuring dosages and durations. It must be emphasized that
this study is a preliminary investigation illustrating the char-
acteristics of patients with MND under hospice care in
Taiwan. Further in-depth investigations are needed.
In conclusion, this study presents an initial approach to the
utilization of hospice care among patients with MND. In
Taiwan, respiratory and feeding problems accounted for a
large measure of the terminal care provided to these patients,
and there is a basis for promoting noninvasive ventilation care
and gastrostomy/jejunostomy as well. Additionally, family
physicians played and continued to have important roles in
hospice care for patients with MND.Acknowledgments
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